Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Breast 2Head & Neck 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Neoplasms 2

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Radiotherapy 47Capecitabine 47Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Moxibustion × Tumor-Agnostic × Clear all
NCT06262542 2024-04-12

Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia

Taichung Armed Forces General Hospital

Phase NA Unknown
60 enrolled
Tumor-Agnostic

Neoplasms

NCT02261571 2014-10-10

Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer

The Comprehensive and Integrative Medicine Institute of South Korea

Phase NA Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡